Furthermore, farboxyfullerene decreased the increase in lipid peroxidation products, decreased MDA levels, and increased superoxide dismutase, glutathione, and catalase levels depleted by ischemia in cerebral ischemia–reperfusion injury [39,40,41,42]. The gene discussed is CAT; the disease is ischemia.